查看購物車
  • English
  • Japanese
  • Korean
全球核酸樣品品管（QC）市場：按產品類型、技術、下游應用、最終用戶和地區/國家分類（2025-2035 年）
市場調查報告書
商品編碼
2027380

全球核酸樣品品管（QC）市場：按產品類型、技術、下游應用、最終用戶和地區/國家分類（2025-2035 年）

Nucleic Acid Sample QC Market - A Global and Regional Analysis: Focus on Product Type, Technology, Downstream Application, End User, and Country - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 171 Pages | 商品交期: 1-5個工作天內

價格

本報告可以在一個工作天內交貨。

核酸樣品品管（QC）市場：簡介

全球核酸樣本品管市場正逐漸成為分子生物學和基因組學工作流程中的關鍵環節，其驅動力在於下游分析前對DNA和RNA樣本的品質、純度、濃度和完整性的保障需求日益成長。隨著實驗室越來越依賴高精度技術，例如次世代定序、PCR、qPCR和其他分子診斷技術，樣本品質控制已成為提高準確性、可重複性和整體工作流程效率的關鍵查核點。

關鍵市場統計資料
預測期 2025-2035
2025年評估 2.789億美元
2035年預測 4.839億美元
年複合成長率 5.66%

2024年全球核酸樣本品管（QC）市場規模為2.672億美元，預計2035年將達到4.839億美元，反映研究、臨床和生物製藥領域的穩定擴張。2025年至2035年，該市場預計將以5.66%的年複合成長率成長，這主要得益於基因組研究投資的增加、個性化醫療應用的拓展以及分子檢測在疾病診斷和藥物研發中日益普及。

此外，自動化程度的廣泛提高、樣本處理能力的提升以及實驗室流程的標準化也推動了市場成長。隨著核酸分析的數量和複雜性不斷增加，對可靠的品管解決方案的需求預計將進一步成長，使該市場成為支撐現代生命科學和診斷工作流程的基石。

核酸樣品品管（QC）市場分類：

細分1：依產品

  • 裝置
  • 耗材和試劑
  • 軟體

依產品類別分類，預計耗材類別將持續主導市場。

從單一產品來看，消耗品佔據主導，到2024年將佔市場佔有率的66.6%。

細分2：依技術

  • 分光光度法
  • 螢光測量
  • 毛細管/微流體控電泳
  • 其他

從技術角度來看，分光光度法領域可望繼續保持主導地位。

以技術類別來看，分光光度法是主導方法，到2024年將佔 40.0%的佔有率。

細分3：下游應用

  • NGS樣品製備與定序
  • PCR/ qPCR篩檢的開發
  • 臨床分子診斷
  • 轉錄組學和基因表現
  • 其他

就下游應用而言，NGS樣品製備和定序領域預計將繼續主導市場。

從下游應用來看，NGS樣品製備和定序推動成長，預計到2024年將佔市場佔有率的39.9%。

細分4：依最終用戶分類

  • 學術研究機構與實驗室
  • 製藥和生物技術公司
  • 受託研究機構
  • 臨床診斷中心
  • 應用測試

依最終用戶分類，學術研究機構和實驗室預計將繼續主導市場。

從最終使用者角度來看，學術研究機構和實驗室是主導，在2024年佔據 44.9%的市場。

北美洲

北美在2024年佔據了最大的市場佔有率，在2025年至2035年的預測期內將保持主導地位。該地區的領先地位得益於其強大的基因組研究生態系統、分子診斷的廣泛應用以及學術界、臨床和生物製藥領域先進的實驗室基礎設施。對精準醫療、基於測序的研究和轉化醫學的大量投資持續推動對可靠的核酸品質控制解決方案的需求。此外，主要廠商的強大實力和自動化技術的早期應用進一步鞏固了北美在該市場的領導地位。

歐洲

歐洲是核酸樣本品質控制的關鍵市場，這得益於其成熟的生命科學產業、不斷擴展的分子檢測能力以及公共和私營部門對生物醫學研究的大力投資。該地區正受益於核酸分析在臨床診斷、疾病研究和藥物開發中日益廣泛的應用。在西歐國家，實驗室品質標準、工作流程的準確性和法規遵循仍然非常重要，這推動了樣本品質控制技術的應用。此外，該地區對基因組學、癌症研究和個人化醫療的日益關注預計將為市場擴張創造持續的機會，使歐洲成為全球整體收入的重要貢獻者。

亞太地區

預計亞太地區將成為預測期內成長最快的地區。該成長主要得益於醫療基礎設施的不斷改善、生物技術和基因組學研究投資的增加，以及分子診斷技術在開發中國家的日益普及。中國、日本、印度、韓國和澳洲等國家對先進實驗室技術的需求不斷成長，這源於人們對疾病檢測、人群基因組學和研究現代化的日益關注。此外，政府支持的增加、實驗室能力的提升以及研究機構數量的成長，預計將加速核酸樣本品質控制解決方案在全部區域的應用。

本報告分析了全球核酸樣本品管（QC）市場，總結了關鍵趨勢、市場影響因素、法律制度、市場規模趨勢和預測、按各個細分市場和地區/主要國家進行的詳細分析、競爭格局以及主要公司的概況。

目錄

執行摘要

範圍和定義

第1章 市場：產業展望

  • 市場概覽
  • 市場吸引力：宏觀與微觀因素分析
  • 監理展望
  • 主要趨勢
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機會

第2章 產品類型

  • 產品類型：摘要
  • 成長佔有率矩陣
  • 裝置
    • 分光光度計
    • 螢光光度計
    • 毛細管/微流體電泳系統
    • 其他
  • 耗材和試劑
    • 分光光度計耗材
    • 基於螢光檢測法的耗材
    • 毛細管/微流體電泳耗材
    • 其他
  • 軟體

第3章 技術

  • 技術概述
  • 成長佔有率矩陣
    • 分光光度法
    • 螢光檢測法
    • 毛細管/微流體電泳
    • 其他

第4章 下游應用

  • 下游應用：概述
  • 成長佔有率矩陣
  • NGS樣品製備與定序
  • PCR/ qPCR篩檢的開發
  • 臨床分子診斷
  • 轉錄組學和基因表現
  • 其他

第5章 最終用戶

  • 最終用戶：摘要
  • 成長佔有率矩陣
  • 學術研究機構與實驗室
  • 製藥和生物技術公司
  • 醫藥受託研究機構
  • 臨床診斷中心
  • 應用測試

第6章 區域

  • 區域：概要
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
    • 區域概覽
    • 市場成長促進因素
    • 威脅市場的因素
    • 國家

第7章 競爭標竿分析與公司概況

  • 產品基準測試
  • 關鍵策略與企業發展：依公司分類
    • 夥伴關係、合作與業務拓展
    • 新產品
  • 企業市場占有率分析
  • 公司簡介
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • DeNovix Inc.
    • Eppendorf SE
    • QIAGEN NV
    • Revvity, Inc.（PerkinElmer, Inc.）
    • Thermo Fisher Scientific Inc.
    • Promega Corporation
    • Danaher Corporation
    • Blue-Ray Biotech Corp.
    • Endress+Hauser Group Services AG
    • Antylia Scientific（Part of Brookfield and La Caisse）
    • Implen GmbH
    • Lumiprobe Corporation

第8章 調查方法

Product Code: BHL3510SA

This report can be delivered within 1 working day.

Introduction of Nucleic Acid Sample QC Market

The global nucleic acid sample QC market is emerging as a vital segment within molecular biology and genomics workflows, driven by the growing need to ensure the quality, purity, concentration, and integrity of DNA and RNA samples before downstream analysis. As laboratories increasingly rely on high-precision techniques such as next-generation sequencing, PCR, qPCR, and other molecular diagnostic applications, sample quality control has become an essential checkpoint for improving accuracy, reproducibility, and overall workflow efficiency.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$278.9 Million
2035 Forecast$483.9 Million
CAGR5.66%

Valued at $267.2 million in 2024, the global nucleic acid sample QC market is projected to reach $483.9 million by 2035, reflecting steady expansion across research, clinical, and biopharmaceutical settings. The market is expected to grow at a CAGR of 5.66% from 2025 to 2035, supported by rising investments in genomics research, expanding applications of personalized medicine, and increasing adoption of molecular testing in disease diagnosis and drug development.

The market is also benefiting from the broader shift toward automation, higher sample throughput, and standardized laboratory processes. As the volume and complexity of nucleic acid-based analysis continue to rise, demand for reliable QC solutions is expected to strengthen, positioning this market as a foundational enabler of modern life science and diagnostic workflows.

Nucleic Acid Sample QC Market Segmentation:

Segmentation 1: Global Nucleic Acid Sample QC by Product

  • Instruments
  • Consumables and Reagents
  • Software

Consumables Segment to Continue Dominating the Nucleic Acid Sample QC Market by Product

Based on product, the nucleic acid sample QC market has been led by consumables, which held a 66.6% share in 2024.

Segmentation 2: Global Nucleic Acid Sample QC Market by Technology

  • Spectrophotometry
  • Fluorometry
  • Capillary/Microfluidic Electrophoresis
  • Others

Spectrophotometry Segment to Continue Dominating the Nucleic Acid Sample QC Market by Technology

Based on the technology, the nucleic acid sample QC market has been led by spectrophotometry, which held a 40.0% share in 2024.

Segmentation 3: Global Nucleic Acid Sample QC Market by Downstream Application

  • NGS Library Preparation and Sequencing
  • PCR/qPCR Assay Development
  • Clinical Molecular Diagnostics
  • Transcriptomics and Gene Expression
  • Others

NGS Library Preparation and Sequencing Segment to Continue Dominating the Nucleic Acid Sample QC Market by Downstream Application

Based on the downstream application, the nucleic acid sample QC market has been led by NGS Library Preparation and Sequencing, which held a 39.9% share in 2024.

Segmentation 4: Global Nucleic Acid Sample QC Market by End User

  • Academic Research Institutes and Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Clinical Diagnostic Centers
  • Applied Testing

Academic Research Institutes and Laboratories Segment to Continue Dominating the Nucleic Acid Sample QC Market by End User

Based on the end user, the nucleic acid sample QC market has been led by academic research institutes and laboratories, which held a 44.9% share in 2024.

Segmentation 5: Global Nucleic Acid Sample QC Market by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Netherlands
    • Poland
    • Portugal
    • Russia
    • Rest-of-Europe
  • Asia-Pacific
    • Australia
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Thailand
    • Taiwan
    • Singapore
    • Indonesia
    • Philippines
    • Rest-of-Asia-Pacific
  • Latin America
    • Argentina
    • Brazil
    • Chile
    • Mexico
    • Colombia
    • Rest-of-Latin America
  • Middle East and Africa
    • K.S.A.
    • U.A.E.
    • South Africa
    • Rest-of-Middle East and Africa

North America

North America accounted for the largest share of the global nucleic acid sample QC market in 2024 and is expected to maintain its leading position throughout the forecast period from 2025 to 2035. The region's dominance is supported by its strong genomics research ecosystem, widespread adoption of molecular diagnostics, and the presence of advanced laboratory infrastructure across academic, clinical, and biopharmaceutical settings. High investment in precision medicine, sequencing-based research, and translational healthcare continues to sustain demand for reliable nucleic acid quality control solutions. In addition, the strong presence of major market players and early adoption of automation further reinforce North America's leadership in this market.

Europe

Europe represents a significant market for nucleic acid sample QC, supported by a well-established life sciences sector, expanding molecular testing capabilities, and strong public and private investment in biomedical research. The region benefits from increasing use of nucleic acid-based analysis in clinical diagnostics, disease research, and pharmaceutical development. Countries across Western Europe continue to emphasize laboratory quality standards, workflow accuracy, and regulatory compliance, which support the adoption of sample QC technologies. Moreover, the region's growing focus on genomics, cancer research, and personalized healthcare is expected to create sustained opportunities for market expansion, making Europe an important contributor to overall global revenue.

Asia-Pacific

Asia-Pacific is expected to be the fastest-growing region in the global nucleic acid sample QC market during the forecast period. Growth in this region is being driven by expanding healthcare infrastructure, rising investments in biotechnology and genomics research, and increasing adoption of molecular diagnostics across developing and developed economies. Countries such as China, Japan, India, South Korea, and Australia are witnessing growing demand for advanced laboratory technologies due to a rising focus on disease detection, population-scale genomics, and research modernization. In addition, increasing government support, improving laboratory capabilities, and a growing number of research institutions are expected to accelerate the adoption of nucleic acid sample QC solutions across Asia-Pacific.

Latin America

Latin America is emerging as a developing market for nucleic acid sample QC, supported by gradual improvements in healthcare infrastructure, rising awareness of molecular diagnostics, and increasing participation in life sciences research. Although the region currently accounts for a smaller share of global revenue compared with North America and Europe, demand is steadily growing in response to the expanding use of nucleic acid testing in infectious disease diagnostics, academic research, and clinical laboratories. Countries such as Brazil, Mexico, and Argentina are expected to remain key contributors to regional growth. Ongoing investments in laboratory capacity and diagnostic modernization are likely to support long-term market development across Latin America.

Middle East and Africa

The Middle East and Africa region holds a comparatively smaller share of the global nucleic acid sample QC market, but it is expected to present gradual growth opportunities over the forecast period. Market expansion is being supported by improving access to molecular testing, increasing healthcare investments, and a rising focus on strengthening diagnostic and research capabilities in selected countries. Demand is particularly driven by the need for better laboratory quality assurance in disease diagnosis, public health testing, and biomedical research applications. While infrastructure and budget limitations remain key challenges in some areas, continued investment in healthcare modernization and laboratory development is expected to support future adoption across the region.

Recent Developments in the Global Nucleic Acid Sample QC Market

  • In August 2025, Analytik Jena expanded its presence in Latin America by establishing its first regional subsidiary, Analytik Jena Brasil Ltda.
  • In March 2025, DeNovix introduced the Helium 1 µL Spectrophotometer, designed for nucleic acid and protein quantification, capable of rapidly assessing dsDNA concentrations and offering key purity ratio results for sample quality control.
  • In February 2025, Analytik Jena announced an update that significantly improves efficiency and digital integration for laboratories using its SPECORD PLUS UV/Vis spectrophotometers. Through the latest version of the ASpect UV software, the instruments can now be operated directly via an external Laboratory Management System (LMS) using a SOAP interface. This allows laboratories to create methods, start measurements, and automatically transfer results back to the LMS without switching between separate software platforms.
  • In April 2024, Eppendorf Group expanded its global footprint with the opening of a new branch office in Johannesburg, South Africa, marking its first direct presence in Africa. The facility, located in Waterfall City, serves as a regional hub for 12 Southern African countries, including Botswana, Namibia, Mozambique, Zambia, Zimbabwe, Lesotho, Angola, Madagascar, Swaziland, Malawi, and Mauritius.

How can this report add value to an organization?

Product/Innovation Strategy: This report helps organizations align product development with evolving laboratory requirements across nucleic acid quality control workflows. It highlights key demand drivers, application trends, and technology adoption patterns, enabling companies to identify innovation opportunities in accuracy, automation compatibility, turnaround time, and workflow integration. It also supports prioritization of R&D investments toward solutions that address emerging needs in research, diagnostics, and biopharmaceutical settings.

Growth/Marketing Strategy: This report supports growth and marketing decisions by identifying high-potential regions, end-user segments, and demand trends shaping the global market. It enables organizations to refine market-entry plans, strengthen value propositions, and develop targeted messaging based on customer needs and purchasing behavior. The insights also help companies allocate commercial resources effectively and design expansion strategies aligned with regional growth opportunities and application-specific demand.

Competitive Strategy: This report provides a structured view of the competitive landscape, helping organizations benchmark their position against established players and emerging participants. It offers insights into market structure, competitive strengths, and strategic differentiation factors such as performance, service, and workflow fit. This enables companies to make informed decisions on partnerships, positioning, portfolio expansion, and competitive response strategies in a steadily evolving market environment.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2024. A historical analysis has been done for the period FY2022-FY2023. The market size has been estimated for FY2024 and projected for the period FY2025-FY2035.
  • The scope of this report has been carefully derived based on interactions with experts in different companies worldwide.
  • The global nucleic acid sample QC market contribution of nucleic acid sample QC, anticipated to be launched in the future, has been calculated based on the historical analysis of the product.
  • Revenues of the companies have been referenced from their annual reports for FY2022 and FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The scope of the report exclusively covers companies that are actively engaged in the development of nucleic acid sample QC products. The instruments, consumables, reagents, and software have been covered in the report. Instruments such as spectrophotometers, fluorometers, capillary/microfluidic electrophoresis systems, and other instruments are considered along with their associated consumables and reagents.
  • The report only provides information related to the kits and reagents, consumables, and instruments used in the QC of nucleic acid samples. Services related to the nucleic acid sample QC have been excluded from the scope of the report.

Primary Research:

The primary sources involve industry experts in nucleic acid sample QC, including the market players offering nucleic acid sample QC. Resources such as CEOs, vice presidents, marketing directors, and salespersons have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others.
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players of the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The global nucleic acid sample QC market is moderately consolidated, with competition shaped by the presence of diversified life science instrumentation companies as well as niche specialists focused on nucleic acid measurement and analytical workflows. Leading participants such as Agilent Technologies, Thermo Fisher Scientific, QIAGEN, Bio-Rad Laboratories, Revvity, and Danaher benefit from strong global distribution networks, established laboratory relationships, and broad capabilities across molecular biology, genomics, and diagnostic workflows. Their competitive strength is further supported by recurring consumables demand, integrated software ecosystems, and ongoing investments in automation and workflow efficiency.

At the same time, specialized companies including DeNovix, Implen, Promega, Blue-Ray Biotech, Lumiprobe, Antylia Scientific, and others contribute to market dynamism by offering focused expertise, flexible solutions, and targeted support for research and clinical laboratory requirements. Competition in this market is driven by measurement accuracy, reproducibility, low sample-volume handling, ease of use, turnaround time, and compatibility with downstream applications such as sequencing, PCR, and molecular diagnostics. As laboratories increasingly prioritize workflow standardization and data reliability, market players are differentiating themselves through innovation, service support, and application-specific performance.

Some prominent names established in the global nucleic acid sample QC market are:

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • DeNovix Inc.
  • Eppendorf SE
  • QIAGEN N.V.
  • Revvity, Inc. (PerkinElmer, Inc.)
  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Danaher Corporation
  • Blue-Ray Biotech Corp.
  • Endress+Hauser
  • Antylia Scientific (Part of Brookfield and La Caisse)
  • Implen GmbH
  • Lumiprobe Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Overview
  • 1.2 Market Attractiveness: Macro and Micro Factor Analysis
  • 1.3 Regulatory Outlook
  • 1.4 Key Trends
    • 1.4.1 Integration with High-Throughput and Automated Workflows
  • 1.5 Market Dynamics
    • 1.5.1 Market Drivers
      • 1.5.1.1 Expanding Adoption of Genetic Testing in Clinical Settings
      • 1.5.1.2 Increasing Funding for Genomic Research
      • 1.5.1.3 Increase in Awareness and Acceptance of Personalized Medicines on a Global Level
    • 1.5.2 Market Restraints
      • 1.5.2.1 High Costs of Advanced QC Technologies
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Development and Utilization of More Biobanks in the Healthcare Segment

2 Product Type

  • 2.1 Product Type Summary
  • 2.2 Growth-Share Matrix
  • 2.3 Instruments
    • 2.3.1 Spectrophotometers
    • 2.3.2 Fluorometers
    • 2.3.3 Capillary/Microfluidic Electrophoresis Systems
    • 2.3.4 Others
  • 2.4 Consumables and Reagents
    • 2.4.1 Spectrophotometry-Based Consumables
    • 2.4.2 Fluorometry-Based Consumables
    • 2.4.3 Capillary/Microfluidic Electrophoresis-Based Consumables
    • 2.4.4 Others
  • 2.5 Software

3 Technology

  • 3.1 Technology Summary
  • 3.2 Growth-Share Matrix
    • 3.2.1 Spectrophotometry
    • 3.2.2 Fluorometry
    • 3.2.3 Capillary/Microfluidic Electrophoresis
    • 3.2.4 Others

4 Downstream Application

  • 4.1 Downstream Applications Summary
  • 4.2 Growth-Share Matrix
  • 4.3 NGS Library Preparation and Sequencing
  • 4.4 PCR/qPCR Assay Development
  • 4.5 Clinical Molecular Diagnostics
  • 4.6 Transcriptomics and Gene Expression
  • 4.7 Other Downstream Applications

5 End User

  • 5.1 End User Summary
  • 5.2 Growth-Share Matrix
  • 5.3 Academic Research Institutes and Laboratories
  • 5.4 Pharmaceutical and Biotechnology Companies
  • 5.5 Contract Research Organizations
  • 5.6 Clinical Diagnostic Centers
  • 5.7 Applied Testing

6 Region

  • 6.1 Regional Summary
  • 6.2 North America
    • 6.2.1 Regional Overview
    • 6.2.2 Driving Factors for Market Growth
    • 6.2.3 Factors Challenging the Market
    • 6.2.4 By Country
      • 6.2.4.1 U.S.
      • 6.2.4.2 Canada
  • 6.3 Europe
    • 6.3.1 Regional Overview
    • 6.3.2 Driving Factors for Market Growth
    • 6.3.3 Factors Challenging the Market
    • 6.3.4 By Country
      • 6.3.4.1 Germany
      • 6.3.4.2 U.K.
      • 6.3.4.3 France
      • 6.3.4.4 Italy
      • 6.3.4.5 Spain
      • 6.3.4.6 Netherlands
      • 6.3.4.7 Poland
      • 6.3.4.8 Portugal
      • 6.3.4.9 Russia
      • 6.3.4.10 Rest-of-Europe
  • 6.4 Asia Pacific
    • 6.4.1 Regional Overview
    • 6.4.2 Driving Factors for Market Growth
    • 6.4.3 Factors Challenging the Market
    • 6.4.4 By Country
      • 6.4.4.1 Australia
      • 6.4.4.2 China
      • 6.4.4.3 India
      • 6.4.4.4 Japan
      • 6.4.4.5 Malaysia
      • 6.4.4.6 South Korea
      • 6.4.4.7 Thailand
      • 6.4.4.8 Taiwan
      • 6.4.4.9 Singapore
      • 6.4.4.10 Indonesia
      • 6.4.4.11 Philippines
      • 6.4.4.12 Rest-of-Asia-Pacific
  • 6.5 Latin America
    • 6.5.1 Regional Overview
    • 6.5.2 Driving Factors for Market Growth
    • 6.5.3 Factors Challenging the Market
    • 6.5.4 By Country
      • 6.5.4.1 Argentina
      • 6.5.4.2 Brazil
      • 6.5.4.3 Chile
      • 6.5.4.4 Mexico
      • 6.5.4.5 Colombia
      • 6.5.4.6 Rest-of-Latin America
  • 6.6 Middle East and Africa
    • 6.6.1 Regional Overview
    • 6.6.2 Driving Factors for Market Growth
    • 6.6.3 Factors Challenging the Market
    • 6.6.4 By Country
      • 6.6.4.1 K.S.A.
      • 6.6.4.2 South Africa
      • 6.6.4.3 U.A.E.
      • 6.6.4.4 Rest-of-Middle East and Africa

7 Competitive Benchmarking & Company Profiles

  • 7.1 Product Benchmarking
    • 7.1.1 Product Benchmarking (by Product Type)
  • 7.2 Key Strategies and Developments (by Company)
    • 7.2.1 Partnerships, Collaborations, and Business Expansions
    • 7.2.2 New Offerings
  • 7.3 Company Share Analysis
  • 7.4 Company Profiles
    • 7.4.1 Agilent Technologies, Inc.
      • 7.4.1.1 Overview
      • 7.4.1.2 Top Products/Product Portfolio
      • 7.4.1.3 Top Competitors
      • 7.4.1.4 Target Customers
      • 7.4.1.5 Key Personnel
      • 7.4.1.6 Analyst View
    • 7.4.2 Bio-Rad Laboratories, Inc.
      • 7.4.2.1 Overview
      • 7.4.2.2 Top Products/Product Portfolio
      • 7.4.2.3 Top Competitors
      • 7.4.2.4 Target Customers
      • 7.4.2.5 Key Personnel
      • 7.4.2.6 Analyst View
    • 7.4.3 DeNovix Inc.
      • 7.4.3.1 Overview
      • 7.4.3.2 Top Products/Product Portfolio
      • 7.4.3.3 Top Competitors
      • 7.4.3.4 Target Customers
      • 7.4.3.5 Key Personnel
      • 7.4.3.6 Analyst View
    • 7.4.4 Eppendorf SE
      • 7.4.4.1 Overview
      • 7.4.4.2 Top Products/Product Portfolio
      • 7.4.4.3 Top Competitors
      • 7.4.4.4 Target Customers
      • 7.4.4.5 Key Personnel
      • 7.4.4.6 Analyst View
    • 7.4.5 QIAGEN N.V.
      • 7.4.5.1 Overview
      • 7.4.5.2 Top Products/Product Portfolio
      • 7.4.5.3 Top Competitors
      • 7.4.5.4 Target Customers
      • 7.4.5.5 Key Personnel
      • 7.4.5.6 Analyst View
    • 7.4.6 Revvity, Inc. (PerkinElmer, Inc.)
      • 7.4.6.1 Overview
      • 7.4.6.2 Top Products/Product Portfolio
      • 7.4.6.3 Top Competitors
      • 7.4.6.4 Target Customers
      • 7.4.6.5 Key Personnel
      • 7.4.6.6 Analyst View
    • 7.4.7 Thermo Fisher Scientific Inc.
      • 7.4.7.1 Overview
      • 7.4.7.2 Top Products/Product Portfolio
      • 7.4.7.3 Top Competitors
      • 7.4.7.4 Target Customers
      • 7.4.7.5 Key Personnel
      • 7.4.7.6 Analyst View
    • 7.4.8 Promega Corporation
      • 7.4.8.1 Overview
      • 7.4.8.2 Top Products/Product Portfolio
      • 7.4.8.3 Top Competitors
      • 7.4.8.4 Target Customers
      • 7.4.8.5 Key Personnel
      • 7.4.8.6 Analyst View
    • 7.4.9 Danaher Corporation
      • 7.4.9.1 Overview
      • 7.4.9.2 Top Products/Product Portfolio
      • 7.4.9.3 Top Competitors
      • 7.4.9.4 Target Customers
      • 7.4.9.5 Key Personnel
      • 7.4.9.6 Analyst View
    • 7.4.10 Blue-Ray Biotech Corp.
      • 7.4.10.1 Overview
      • 7.4.10.2 Top Products/Product Portfolio
      • 7.4.10.3 Top Competitors
      • 7.4.10.4 Target Customers
      • 7.4.10.5 Key Personnel
      • 7.4.10.6 Analyst View
    • 7.4.11 Endress+Hauser Group Services AG
      • 7.4.11.1 Overview
      • 7.4.11.2 Top Products/Product Portfolio
      • 7.4.11.3 Top Competitors
      • 7.4.11.4 Target Customers
      • 7.4.11.5 Key Personnel
      • 7.4.11.6 Analyst View
    • 7.4.12 Antylia Scientific (Part of Brookfield and La Caisse)
      • 7.4.12.1 Overview
      • 7.4.12.2 Top Products/Product Portfolio
      • 7.4.12.3 Top Competitors
      • 7.4.12.4 Target Customers
      • 7.4.12.5 Key Personnel
      • 7.4.12.6 Analyst View
    • 7.4.13 Implen GmbH
      • 7.4.13.1 Overview
      • 7.4.13.2 Top Products/Product Portfolio
      • 7.4.13.3 Top Competitors
      • 7.4.13.4 Target Customers
      • 7.4.13.5 Key Personnel
      • 7.4.13.6 Analyst View
    • 7.4.14 Lumiprobe Corporation
      • 7.4.14.1 Overview
      • 7.4.14.2 Top Products/Product Portfolio
      • 7.4.14.3 Top Competitors
      • 7.4.14.4 Target Customers
      • 7.4.14.5 Key Personnel
      • 7.4.14.6 Analyst View

8 Research Methodology

  • 8.1 Data Sources
    • 8.1.1 Primary Data Sources
    • 8.1.2 Secondary Data Sources
    • 8.1.3 Data Triangulation
  • 8.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Nucleic Acid Sample QC Market (by Scenario), $Million, 2024, 2030, and 2035
  • Figure 2: Global Nucleic Acid Sample QC Market (by Region), $Million, 2024, 2030, and 2035
  • Figure 3: Global Nucleic Acid Sample QC Market (by Product Type), $Million, 2024, 2030, and 2035
  • Figure 4: Global Nucleic Acid Sample QC Market (by Technology), $Million, 2024, 2030, and 2035
  • Figure 5: Global Nucleic Acid Sample QC Market (by Downstream Application), $Million, 2024, 2030, and 2035
  • Figure 6: Global Nucleic Acid Sample QC Market (by End User), $Million, 2024, 2030, and 2035
  • Figure 7: Global Nucleic Acid Sample QC Market, $Million, 2018-2035
  • Figure 8: Global Nucleic Acid Sample QC Market (by Product Type), $Million, 2024, 2030, and 2035
  • Figure 9: Growth-Share Analysis for Global Nucleic Acid Sample QC Market (by Product Type), 2024-2035
  • Figure 10: Global Nucleic Acid Sample QC Market (Instruments), $Million, 2024-2035
  • Figure 11: Global Nucleic Acid Sample QC Market (Spectrophotometers), $Million, 2024-2035
  • Figure 12: Global Nucleic Acid Sample QC Market (Fluorometers), $Million, 2024-2035
  • Figure 13: Global Nucleic Acid Sample QC Market (Capillary/Microfluidic Electrophoresis Systems), $Million, 2024-2035
  • Figure 14: Global Nucleic Acid Sample QC Market (Others), $Million, 2024-2035
  • Figure 15: Global Nucleic Acid Sample QC Market (Consumables and Reagents), $Million, 2024-2035
  • Figure 16: Global Nucleic Acid Sample QC Market (Spectrophotometry-Based Consumables), $Million, 2024-2035
  • Figure 17: Global Nucleic Acid Sample QC Market (Fluorometry-Based Consumables), $Million, 2024-2035
  • Figure 18: Global Nucleic Acid Sample QC Market (Capillary/Microfluidic Electrophoresis-Based Consumables), $Million, 2024-2035
  • Figure 19: Global Nucleic Acid Sample QC Market (Others), $Million, 2024-2035
  • Figure 20: Global Nucleic Acid Sample QC Market (Software), $Million, 2024-2035
  • Figure 21: Global Nucleic Acid Sample QC Market (by Technology), $Million, 2024, 2030, and 2035
  • Figure 22: Growth-Share Analysis for Global Nucleic Acid Sample QC Market (by Technology), 2024-2035
  • Figure 23: Global Nucleic Acid Sample QC Market (Spectrophotometry), $Million, 2024-2035
  • Figure 24: Global Nucleic Acid Sample QC Market (Fluorometry), $Million, 2024-2035
  • Figure 25: Global Nucleic Acid Sample QC Market (Capillary Electrophoresis/Microfluidic Electrophoresis), $Million, 2024-2035
  • Figure 26: Global Nucleic Acid Sample QC Market (Others), $Million, 2024-2035
  • Figure 27: Global Nucleic Acid Samples QC Market (by Downstream Applications), $Million, 2024, 2030, and 2035
  • Figure 28: Growth-Share Analysis for Nucleic Acid Sample QC Market (by Downstream Applications), 2024-2035
  • Figure 29: Global Nucleic Acid Sample QC Market (NGS Library Preparation and Sequencing), $Million, 2024-2035
  • Figure 30: Global Nucleic Acid Sample QC Market (PCR/qPCR Assay Development), $Million, 2024-2035
  • Figure 31: Global Nucleic Acid Sample QC Market (Clinical Molecular Diagnostics), $Million, 2024-2035
  • Figure 32: Global Nucleic Acid Sample QC Market (Transcriptomics and Gene Expression), $Million, 2024-2035
  • Figure 33: Global Nucleic Acid Sample QC Market (Other Downstream Applications), $Million, 2024-2035
  • Figure 34: Global Nucleic Acid Sample QC Market (by End User), $Million, 2024-2035
  • Figure 35: Growth-Share Analysis for Global Nucleic Acid Sample QC Market (by End User), 2024-2035
  • Figure 36: Global Nucleic Acid Sample QC Market (Academic Research Institutes and Laboratories), $Million, 2024-2035
  • Figure 37: Global Nucleic Acid Sample QC Market (Pharmaceutical and Biotechnology Companies), $Million, 2024-2035
  • Figure 38: Global Nucleic Acid Sample QC Market (Contract Research Organizations), $Million, 2024-2035
  • Figure 39: Global Nucleic Acid Sample QC Market (Clinical Diagnostic Centers), $Million, 2024-2035
  • Figure 40: Global Nucleic Acid Sample QC Market (Applied Testing), $Million, 2024-2035
  • Figure 41: North America Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 42: U.S. Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 43: Canada Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 44: Europe Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 45: Germany Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 46: U.K. Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 47: France Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 48: Italy Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 49: Spain Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 50: Netherlands Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 51: Poland Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 52: Portugal Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 53: Russia Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 54: Rest-of-Europe Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 55: Asia Pacific Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 56: Australia Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 57: China Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 58: India Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 59: Japan Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 60: Malaysia Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 61: South Korea Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 62: Thailand Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 63: Taiwan Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 64: Singapore Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 65: Indonesia Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 66: Philippines Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 67: Rest-of-Asia-Pacific Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 68: Latin America Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 69: Argentina Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 70: Brazil Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 71: Chile Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 72: Mexico Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 73: Colombia Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 74: Rest-of-Latin America Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 75: Middle East and Africa Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 76: Saudi Arabia Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 77: South Africa Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 78: U.A.E Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 79: Rest-of-Middle East and Africa Nucleic Acid Sample QC Market, $Million, 2024-2035
  • Figure 80: Company Share Analysis, Global Nucleic Acid Sample QC Market
  • Figure 81: Data Triangulation
  • Figure 82: Top-Down and Bottom-Up Approach
  • Figure 83: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Impact Analysis- Macro and Micro Factors, Global Nucleic Acid Sample QC Market
  • Table 3: Global Nucleic Acid Sample QC Market Regulatory Landscape in the U.S., EU, Japan, China, and India
  • Table 4: Impact Analysis of Market Dynamics, 2024-2035
  • Table 5: Global Nucleic Acid Sample QC Market (by Region), $Million, 2024-2035
  • Table 6: Nucleic Acid Sample QC Market, Product Benchmarking (by Product Type)